Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction

por Fortunato, O, Boeri, M, Moro, M, Verri, C, Mensah, M, Conte, D, Caleca, L, Roz, L, Pastorino, U, Sozzi, G
Publicado 2014